Yabe D, Nakamura J, Kaneto H et al (2020) Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Drug misuse* involves taking a drug for nonmedical purposes, or in a way thats not approved
The following symptoms are not
Zanchi A, Burnier M, Muller ME et al (2020) Acute and chronic effects of SGLT2 inhibitor empagliflozin on renal oxygenation and blood pressure control in nondiabetic normotensive subjects: a randomized, placebo-controlled trial
If pregnant, breastfeeding, or currently taking medication, consult a healthcare professional before use
Influencers post dramatic before-and-after photos